Comments on: FDA grants RMAT designation to Novartis’ Kymriah in follicular cancer /news/novartis-kymriah-fda-rmat/ The leading site for news and procurement in the pharmaceutical industry Wed, 22 Apr 2020 11:50:15 +0000 hourly 1 https://wordpress.org/?v=6.7.2